Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Rink, TJ
   Can you stand the heat of today's drug discovery?
   DRUG DISCOVERY TODAY
   
   T.J. Rink, "Can you stand the heat of today's drug discovery?", DRUG DISC T, 5(6), 2000, pp. 226-227
2. Rink, TJ
   A Boston T party
   DRUG DISCOVERY TODAY
   
   T.J. Rink, "A Boston T party", DRUG DISC T, 4(6), 1999, pp. 249-250
3. GEDULIN BR; RINK TJ; YOUNG AA
   DOSE-RESPONSE FOR GLUCAGONOSTATIC EFFECT OF AMYLIN IN RATS
   Metabolism, clinical and experimental
   
   B.R. Gedulin et al., "DOSE-RESPONSE FOR GLUCAGONOSTATIC EFFECT OF AMYLIN IN RATS", Metabolism, clinical and experimental, 46(1), 1997, pp. 67-70
4. GEDULIN BR; JODKA CM; GREEN DE; RINK TJ; YOUNG AA
   REVERSAL OF AMYLIN-INHIBITION OF GASTRIC-EMPTYING BY INSULIN-INDUCED HYPOGLYCEMIA
   Journal of investigative medicine
   
   B.R. Gedulin et al., "REVERSAL OF AMYLIN-INHIBITION OF GASTRIC-EMPTYING BY INSULIN-INDUCED HYPOGLYCEMIA", Journal of investigative medicine, 44(1), 1996, pp. 160-160
5. YOUNG AA; VINE W; GEDULIN BR; PITTNER R; JANES S; GAETA LSL; PERCY A; MOORE CX; KODA JE; RINK TJ; BEAUMONT K
   PRECLINICAL PHARMACOLOGY OF PRAMLINTIDE IN THE RAT - COMPARISONS WITHHUMAN AND RAT AMYLIN
   Drug development research
   
   A.A. Young et al., "PRECLINICAL PHARMACOLOGY OF PRAMLINTIDE IN THE RAT - COMPARISONS WITHHUMAN AND RAT AMYLIN", Drug development research, 37(4), 1996, pp. 231-248
6. YOUNG AA; GEDULIN BR; RINK TJ
   DOSE-RESPONSES FOR THE SLOWING OF GASTRIC-EMPTYING IN A RODENT MODEL BY GLUCAGON-LIKE PEPTIDE (7-36)NH2, AMYLIN, CHOLECYSTOKININ, AND OTHERPOSSIBLE REGULATORS OF NUTRIENT-UPTAKE
   Metabolism, clinical and experimental
   
   A.A. Young et al., "DOSE-RESPONSES FOR THE SLOWING OF GASTRIC-EMPTYING IN A RODENT MODEL BY GLUCAGON-LIKE PEPTIDE (7-36)NH2, AMYLIN, CHOLECYSTOKININ, AND OTHERPOSSIBLE REGULATORS OF NUTRIENT-UPTAKE", Metabolism, clinical and experimental, 45(1), 1996, pp. 1-3
7. VINE W; BEAUMONT K; GEDULIN B; PITTNER R; MOORE CX; RINK TJ; YOUNG AA
   COMPARISON OF THE IN-VITRO AND IN-VIVO PHARMACOLOGY OF ADRENOMEDULLIN, CALCITONIN-GENE-RELATED PEPTIDE AND AMYLIN IN RATS
   European journal of pharmacology
   
   W. Vine et al., "COMPARISON OF THE IN-VITRO AND IN-VIVO PHARMACOLOGY OF ADRENOMEDULLIN, CALCITONIN-GENE-RELATED PEPTIDE AND AMYLIN IN RATS", European journal of pharmacology, 314(1-2), 1996, pp. 115-121
8. YOUNG AA; WANG MW; GEDULIN B; RINK TJ; PITTNER R; BEAUMONT K
   DIABETOGENIC EFFECTS OF SALMON-CALCITONIN ARE ATTRIBUTABLE TO AMYLIN-LIKE ACTIVITY
   Metabolism, clinical and experimental
   
   A.A. Young et al., "DIABETOGENIC EFFECTS OF SALMON-CALCITONIN ARE ATTRIBUTABLE TO AMYLIN-LIKE ACTIVITY", Metabolism, clinical and experimental, 44(12), 1995, pp. 1581-1589
9. GEDULIN BR; JODKA CM; GREEN DE; RINK TJ; YOUNG AA
   ASSESSMENT OF GASTRIC-EMPTYING FROM APPEARANCE IN PLASMA OF H-3 FROM GAVAGED [3-H-3]GLUCOSE IN CONSCIOUS RATS - EFFECTS OF AMYLIN
   Gastroenterology
   
   B.R. Gedulin et al., "ASSESSMENT OF GASTRIC-EMPTYING FROM APPEARANCE IN PLASMA OF H-3 FROM GAVAGED [3-H-3]GLUCOSE IN CONSCIOUS RATS - EFFECTS OF AMYLIN", Gastroenterology, 108(4), 1995, pp. 604-604
10. PITTNER RA; WOLFELOPEZ D; YOUNG AA; RINK TJ
    AMYLIN AND EPINEPHRINE HAVE NO DIRECT EFFECT ON GLUCOSE-TRANSPORT IN ISOLATED RAT SOLEUS MUSCLE
    FEBS letters
    
    R.A. Pittner et al., "AMYLIN AND EPINEPHRINE HAVE NO DIRECT EFFECT ON GLUCOSE-TRANSPORT IN ISOLATED RAT SOLEUS MUSCLE", FEBS letters, 365(1), 1995, pp. 98-100
11. YOUNG AA; GEDULIN B; VINE W; PERCY A; RINK TJ
    GASTRIC-EMPTYING IS ACCELERATED IN DIABETIC BB RATS AND IS SLOWED BY SUBCUTANEOUS INJECTIONS OF AMYLIN
    Diabetologia
    
    A.A. Young et al., "GASTRIC-EMPTYING IS ACCELERATED IN DIABETIC BB RATS AND IS SLOWED BY SUBCUTANEOUS INJECTIONS OF AMYLIN", Diabetologia, 38(6), 1995, pp. 642-648
12. BEAUMONT K; MOORE CX; PITTNER RA; PRICKETT KS; GAETA LSL; RINK TJ; YOUNG AA
    DIFFERENTIAL ANTAGONISM OF AMYLINS METABOLIC AND VASCULAR ACTIONS WITH AMYLIN RECEPTOR ANTAGONISTS
    Canadian journal of physiology and pharmacology
    
    K. Beaumont et al., "DIFFERENTIAL ANTAGONISM OF AMYLINS METABOLIC AND VASCULAR ACTIONS WITH AMYLIN RECEPTOR ANTAGONISTS", Canadian journal of physiology and pharmacology, 73(7), 1995, pp. 1025-1029
13. BEAUMONT K; PITTNER RA; MOORE CX; WOLFELOPEZ D; PRICKETT KS; YOUNG AA; RINK TJ
    REGULATION OF MUSCLE GLYCOGEN-METABOLISM BY CGRP AND AMYLIN - CGRP RECEPTORS NOT INVOLVED
    British Journal of Pharmacology
    
    K. Beaumont et al., "REGULATION OF MUSCLE GLYCOGEN-METABOLISM BY CGRP AND AMYLIN - CGRP RECEPTORS NOT INVOLVED", British Journal of Pharmacology, 115(5), 1995, pp. 713-715
14. VINE W; SMITH P; LACHAPPELL R; RINK TJ; YOUNG AA
    LACTATE PRODUCTION FROM THE RAT HINDLIMB IS INCREASED AFTER GLUCOSE-ADMINISTRATION AND IS SUPPRESSED BY A SELECTIVE AMYLIN ANTAGONIST - EVIDENCE FOR ACTION OF ENDOGENOUS AMYLIN IN SKELETAL-MUSCLE
    Biochemical and biophysical research communications
    
    W. Vine et al., "LACTATE PRODUCTION FROM THE RAT HINDLIMB IS INCREASED AFTER GLUCOSE-ADMINISTRATION AND IS SUPPRESSED BY A SELECTIVE AMYLIN ANTAGONIST - EVIDENCE FOR ACTION OF ENDOGENOUS AMYLIN IN SKELETAL-MUSCLE", Biochemical and biophysical research communications, 216(2), 1995, pp. 554-559
15. PITTNER RA; ALBRANDT K; BEAUMONT K; GAETA LSL; KODA JE; MOORE CX; RITTENHOUSE J; RINK TJ
    MOLECULAR PHYSIOLOGY OF AMYLIN
    Journal of cellular biochemistry
    
    R.A. Pittner et al., "MOLECULAR PHYSIOLOGY OF AMYLIN", Journal of cellular biochemistry, 55, 1994, pp. 19-28
16. YOUNG AA; RINK TJ; VINE W; GEDULIN B
    AMYLIN AND SYNDROME-X
    Drug development research
    
    A.A. Young et al., "AMYLIN AND SYNDROME-X", Drug development research, 32(2), 1994, pp. 90-99
17. RINK TJ
    GENETICS - IN SEARCH OF A SATIETY FACTOR
    Nature
    
    T.J. Rink, "GENETICS - IN SEARCH OF A SATIETY FACTOR", Nature, 372(6505), 1994, pp. 406-407
18. YOUNG AA; GEDULIN B; GAETA LSL; PRICKETT KS; BEAUMONT K; LARSON E; RINK TJ
    SELECTIVE AMYLIN ANTAGONIST SUPPRESSES RISE IN PLASMA LACTATE AFTER INTRAVENOUS GLUCOSE IN THE RAT - EVIDENCE FOR A METABOLIC ROLE OF ENDOGENOUS AMYLIN
    FEBS letters
    
    A.A. Young et al., "SELECTIVE AMYLIN ANTAGONIST SUPPRESSES RISE IN PLASMA LACTATE AFTER INTRAVENOUS GLUCOSE IN THE RAT - EVIDENCE FOR A METABOLIC ROLE OF ENDOGENOUS AMYLIN", FEBS letters, 343(3), 1994, pp. 237-241
19. BEAUMONT K; MOORE CX; PITTNER R; PRICKETT K; GAETA LSL; RINK TJ; YOUNG AA
    DIFFERENTIAL PHARMACOLOGICAL ANTAGONISM OF AMYLIN AND CGRP RECEPTORS
    Diabetologia
    
    K. Beaumont et al., "DIFFERENTIAL PHARMACOLOGICAL ANTAGONISM OF AMYLIN AND CGRP RECEPTORS", Diabetologia, 37, 1994, pp. 10000116-10000116
20. PITTNER RA; WOLFELOPEZ D; LUPIEN J; BEAUMONT K; YOUNG AA; RINK TJ
    AMYLIN INCREASES CYCLIC-AMP LEVELS AND STIMULATES GLYCOGENOLYSIS IN RAT SKELETAL-MUSCLE
    Diabetologia
    
    R.A. Pittner et al., "AMYLIN INCREASES CYCLIC-AMP LEVELS AND STIMULATES GLYCOGENOLYSIS IN RAT SKELETAL-MUSCLE", Diabetologia, 37, 1994, pp. 10000117-10000117
21. RINK TJ; LARSON E; YOUNG AA; GEDULIN B
    EFFECTS OF AMYLIN ON LACTATE METABOLISM IN THE RAT - STUDIES USING HYPERLACTEMIC HYPERGLYCEMIC CLAMPS/
    Diabetologia
    
    T.J. Rink et al., "EFFECTS OF AMYLIN ON LACTATE METABOLISM IN THE RAT - STUDIES USING HYPERLACTEMIC HYPERGLYCEMIC CLAMPS/", Diabetologia, 37, 1994, pp. 10000117-10000117
22. BEAUMONT K; KENNEY MA; YOUNG AA; RINK TJ
    HIGH-AFFINITY AMYLIN BINDING-SITES IN RAT-BRAIN
    Molecular pharmacology
    
    K. Beaumont et al., "HIGH-AFFINITY AMYLIN BINDING-SITES IN RAT-BRAIN", Molecular pharmacology, 44(3), 1993, pp. 493-497
23. YOUNG AA; RINK TJ; WANG MW
    DOSE-RESPONSE CHARACTERISTICS FOR THE HYPERGLYCEMIC, HYPERLACTEMIC, HYPOTENSIVE AND HYPOCALCEMIC ACTIONS OF AMYLIN AND CALCITONIN GENE-RELATED PEPTIDE-I (CGRP-ALPHA) IN THE FASTED, ANESTHETIZED RAT
    Life sciences
    
    A.A. Young et al., "DOSE-RESPONSE CHARACTERISTICS FOR THE HYPERGLYCEMIC, HYPERLACTEMIC, HYPOTENSIVE AND HYPOCALCEMIC ACTIONS OF AMYLIN AND CALCITONIN GENE-RELATED PEPTIDE-I (CGRP-ALPHA) IN THE FASTED, ANESTHETIZED RAT", Life sciences, 52(21), 1993, pp. 1717-1726
24. YOUNG AA; GEDULIN B; LARSON E; RINK TJ
    EVIDENCE FROM STUDIES USING A SPECIFIC BLOCKER FOR A METABOLIC EFFECTOF ENDOGENOUS AMYLIN IN-VIVO
    Diabetologia
    
    A.A. Young et al., "EVIDENCE FROM STUDIES USING A SPECIFIC BLOCKER FOR A METABOLIC EFFECTOF ENDOGENOUS AMYLIN IN-VIVO", Diabetologia, 36, 1993, pp. 10000136-10000136
25. MOORE C; RINK TJ
    AMYLIN ACTIVATES ADENYLYL CYCLASE IN RAT SOLEUS MUSCLE
    Diabetes
    
    C. Moore e T.J. Rink, "AMYLIN ACTIVATES ADENYLYL CYCLASE IN RAT SOLEUS MUSCLE", Diabetes, 42, 1993, pp. 257-257
26. YOUNG AA; COOPER GJS; CARLO P; RINK TJ; WANG MW
    RESPONSE TO INTRAVENOUS INJECTIONS OF AMYLIN AND GLUCAGON IN FASTED, FED, AND HYPOGLYCEMIC RATS
    The American journal of physiology
    
    A.A. Young et al., "RESPONSE TO INTRAVENOUS INJECTIONS OF AMYLIN AND GLUCAGON IN FASTED, FED, AND HYPOGLYCEMIC RATS", The American journal of physiology, 264(6), 1993, pp. 943-950
27. RINK TJ; BEAUMONT K; KODA J; YOUNG A
    STRUCTURE AND BIOLOGY OF AMYLIN
    Trends in pharmacological sciences
    
    T.J. Rink et al., "STRUCTURE AND BIOLOGY OF AMYLIN", Trends in pharmacological sciences, 14(4), 1993, pp. 113-118